| Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii G Liu, DB Catacutan, K Rathod, K Swanson, W Jin, JC Mohammed, ... Nature Chemical Biology 19 (11), 1342-1350, 2023 | 214 | 2023 |
| Generative AI for designing and validating easily synthesizable and structurally novel antibiotics K Swanson, G Liu, DB Catacutan, A Arnold, J Zou, JM Stokes Nature Machine Intelligence 6 (3), 338-353, 2024 | 70 | 2024 |
| Machine learning in preclinical drug discovery DB Catacutan, J Alexander, A Arnold, JM Stokes Nature Chemical Biology 20 (8), 960-973, 2024 | 33 | 2024 |
| Generative AI for designing and validating easily synthesizable and structurally novel antibiotics. Nat Mach Intell 6, 338–353 K Swanson, G Liu, DB Catacutan, A Arnold, J Zou, JM Stokes | 6 | 2024 |
| Exploiting the fitness cost of metallo-β-lactamase expression can overcome antibiotic resistance in bacterial pathogens MM Tu, LA Carfrae, K Rachwalski, S French, D Catacutan, R Gordzevich, ... Nature Microbiology, 1-13, 2025 | 1 | 2025 |
| The fitness cost of metallo-β-lactamase expression is a potential target for new therapeutic approaches to carbapenem resistance M Tu, L Carfrae, K Rachwalski, S French, D Catacutan, R Gordzevich, ... | 1 | 2023 |
